Extended Research →
Verdict, decision matrix, deep dives, sourcing notes & full sources

N-Acetyl-Cysteine (NAC)

Extensively Studied

Cheap, daily-safe glutathione precursor with massive evidence base — FDA-approved for paracetamol overdose (gold-standard antidote since… | Supplement · Powder

Aliases (8)
NAC · N-Acetylcysteine · Acetylcysteine · Mucomyst · Acetadote · Fluimucil · Parvolex · NAC FA (free acid)
TYPICAL DOSE
600-1200 mg/day with food. Single morning dose …
ROUTE
Oral (powder)
CYCLE
None
STORAGE
Room temp; sealed, dry
Did you know? You can suggest edits to improve this compound's information.
Submitted via email — no account required.
Suggest an edit
Mixing & scoop math Powder
Mixing
  • Mix into 8-16 oz cold water (or sports drink / protein shake). Most powders dissolve in < 30 sec with a brisk stir.
  • If using a shaker, add liquid first, then powder, then shake — minimizes foam and clumps.
  • Hot water is fine for most amino acids and creatine; avoid for heat-sensitive compounds (NAC degrades above ~60 °C).
  • Drink within 5-10 min of mixing — most powders are stable in solution but taste degrades.
Overview TL;DR

Cheap, daily-safe glutathione precursor with massive evidence base — FDA-approved for paracetamol overdose (gold-standard antidote since 1976), A-tier psychiatric (OCD, trichotillomania, skin-picking), B-tier for addiction + cocaine craving + gambling. Crosses the BBB and replenishes brain glutathione better than direct GSH supplementation. Already in Dylan's V4 stack at 1200 mg/day — verdict is CONFIRMED-IN-USE. Mechanism stack is uniquely fit-for-purpose for an MMA athlete with daily subconcussive impact: it covers both oxidative stress (GSH precursor + direct ROS scavenger) and excitotoxicity (glutamate modulation via xCT/mGluR2/3) in one molecule. Continue at 1200 mg/day; consider 2400 mg/day on heavy sparring days as a post-impact rescue protocol.

Mechanism of action

NAC is the N-acetylated form of L-cysteine. The acetyl group makes the molecule more stable, more bioavailable, and less prone to oxidation than free cysteine, which gets oxidized to insoluble cystine in air and stomach acid. After oral absorption (~6-10% systemic bioavailability — low but functionally adequate), NAC is deacetylated in the gut wall and liver, releasing L-cysteine, which then enters multiple downstream pathways:

  1. Glutathione (GSH) synthesis — the main story. GSH is a tripeptide of glutamate-cysteine-glycine, synthesized in two ATP-dependent steps. Cysteine is the rate-limiting substrate in nearly all human tissue including brain, liver, lung. GSH is the body's master endogenous antioxidant — recycles vitamin C and vitamin E, neutralizes hydrogen peroxide via glutathione peroxidase (GPX), conjugates xenobiotics for excretion via glutathione-S-transferase (GST), and protects mitochondrial membrane lipids. Brain GSH declines with age and is depleted after TBI / subconcussive impact. NAC at 1200-2400 mg/day reliably raises plasma + tissue GSH in healthy and depleted populations.

  2. Direct free-radical scavenger. The free sulfhydryl (-SH) on cysteine donates an electron to neutralize hydroxyl radicals, peroxynitrite, hypochlorous acid, and other reactive oxygen/nitrogen species. This is mechanism-independent of GSH synthesis and acts within minutes of dosing. Less potent per-mole than GSH itself but works in compartments where GSH can't reach.

  3. Glutamate modulation via the cystine-glutamate antiporter (xCT / system Xc-). This is the brain-specific mechanism that distinguishes NAC from generic antioxidants. In glial cells, the xCT antiporter exchanges intracellular glutamate for extracellular cystine (oxidized cysteine dimer). NAC raises extracellular cystine → drives the antiporter → exports glutamate out of the synapse and into glia, where it's recycled. The exported glutamate stimulates mGluR2/3 presynaptic autoreceptors, which inhibit further synaptic glutamate release. Net effect: reduces tonic glutamate tone in cortex, striatum, and nucleus accumbens. This is the mechanism behind NAC's psychiatric effects — OCD, trichotillomania, addiction craving, schizophrenia adjunct.

  4. Mucolytic — disulfide bond reduction. The free -SH cleaves disulfide bonds in mucin glycoproteins, breaking up thick mucus. This is the mechanism behind Mucomyst inhalation for cystic fibrosis and COPD. Not directly relevant to nootropic use, but explains the sulfur smell and explains why some users report runnier nasal mucus on NAC.

  5. Heavy-metal chelation. Free thiol binds mercury, lead, arsenic, cadmium for excretion. Modest but real chelation activity at supplement doses.

  6. Anti-inflammatory. Suppresses NF-κB activation; reduces IL-6, TNF-α, IL-1β; attenuates microglial activation in models of neuroinflammation. Convergent mechanism with curcumin and astaxanthin.

  7. Paracetamol overdose antidote (the original FDA indication). Paracetamol (acetaminophen) at toxic doses is metabolized to NAPQI, a reactive electrophile that depletes hepatic GSH and causes liver necrosis. NAC restores GSH and directly scavenges NAPQI. Given IV (Acetadote) within 8-10 hours of overdose, mortality drops from ~30% to <5%. Gold-standard, on the WHO Essential Medicines List.

Pharmacokinetics No data
Pharmacokinetics data not available for this compound.
No half-life mentions found in the source notes.
Quality indicators4 checks
Micronized particle size
Fine micronized powder dissolves cleanly. Coarse grit suggests low-grade processing.
Dissolves cleanly
Most quality powders disperse fully in 4-6 oz water with a 30s stir.
!
Taste matches label
Tasteless ingredients (creatine, glycine) should be tasteless. Bitter chalk = filler concern.
Color uniform across batches
Color drift between bottles suggests inconsistent sourcing or degradation in transit.
What to expect Generic
  1. 1
    First dose
    For stim-class powders: acute effect within 30-60 min.
  2. 2
    Week 1-2
    For volumizers (creatine, betaine): muscle fullness builds.
  3. 3
    Week 2-4
    Performance gains plateau into a new baseline.
  4. 4
    Ongoing
    Maintenance dose continuous; cycle off only if specific indication.
Side effects + safety
  • Common (>10% users):

    • Sulfur / egg-like burp or breath — characteristic, dose-dependent, especially at >1200 mg empty stomach. Reduced by taking with food, splitting doses, or switching to enteric-coated form.
    • Mild GI upset / nausea — usually at higher doses on empty stomach.
  • Less common (1-10%):

    • Headache (mild)
    • Diarrhea / loose stool (typically transient, dose-related)
    • Skin rash (mild; rare in oral form, more common in IV)
  • Rare-serious (<1% but worth knowing):

    • Anaphylactoid reaction (IV form mainly): Histamine-release reaction with rash, bronchospasm, hypotension during IV administration. Almost exclusively IV. Oral NAC has near-zero risk of this.
    • Paradoxical bronchospasm (asthmatics, mainly inhaled form): Mucomyst inhalation can trigger acute bronchospasm in some asthmatics. Pre-treat with bronchodilator. Oral form has minimal asthma risk; some asthma patients report oral NAC reduces exacerbations (mucolytic + antioxidant).
    • Hypotension at very high doses combined with nitroglycerin or other nitrate vasodilators: Real interaction (see drug interactions). Sub-clinical at supplement doses unless on nitrates.
    • Theoretical bleeding risk with anticoagulants: NAC has mild antiplatelet activity in vitro. No bleeding events documented at supplement doses.
    • Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis: Single case reports, extremely rare, IV form. Not a routine concern at oral supplement doses.
  • Specific watch periods: None standard. Asthmatics starting oral NAC for the first time should monitor for any breathing change in the first 1-2 weeks (very low probability of bronchospasm but worth noting).

  • Pregnancy / lactation: Used clinically in pregnancy (paracetamol overdose treatment in pregnant women is standard). FDA Pregnancy Category B. No teratogenicity signal. Lactation data limited; generally considered safe.

  • Long-term safety: Multiple human trials at 1200-2400 mg/day for 6-24 months show no chronic toxicity signal. COPD patients have used 600 mg BID for years. Maximum-tested daily dose in humans without serious adverse events: 8 g/day short-term. Practical chronic ceiling: 2400 mg/day for routine use; 4000 mg/day for short rescue periods.

Upper safe intake:

  • No formal NOAEL / tolerable upper intake established by EFSA/FDA (it's a drug, not a nutrient).
  • 2400 mg/day chronic = clinical OCD trial standard, well-tolerated.
  • 4000 mg/day = used in TBI rescue protocol for ~4 days, well-tolerated short-term.
  • 8000 mg/day = used in some IV paracetamol loading regimens, short-term clinical use only.
Interactions12 compounds
  • glycineSynergistic
    GSH is gamma-Glu-Cys-Gly. Cysteine is rate-limiting in *most* tissues, but glycine becomes co-limiting in older adults and during chronic illness (Sekhar 201…
  • curcumin (V4 — Doctor's Best Curcumin Phytosome 500 mg)Synergistic
    Both anti-inflammatory, both Nrf2 activators, both hit microglial NF-κB. Convergent on neuroinflammation. Stack in same morning dose. Mechanism overlap is pa…
  • astaxanthin (V5 add)Synergistic
    Astaxanthin protects mitochondrial + neuronal membranes from lipid peroxidation; NAC replenishes the GSH pool that recycles oxidized vitamin E and supports g…
  • omega-3 / DHA (V4 — Carlson Super DHA Gems 2 g)Synergistic
    DHA is the most peroxidation-vulnerable fatty acid in brain membranes. NAC + GSH protects DHA from oxidation; astaxanthin also covers this. Triad mechanism —…
  • vitamin C (V4 — CGN 500 mg)Synergistic
    Vitamin C regenerates oxidized vitamin E; NAC regenerates GSH which regenerates vitamin C. Network antioxidant cycle. Already in V4 — no change needed.
  • magnesium (V4 — Magtein + Mg Glycinate)Synergistic
    NMDA receptor magnesium block + NAC's xCT-mediated glutamate reduction = layered protection against glutamate excitotoxicity. Particularly relevant for post-…
  • agmatineSynergistic
    Direct NMDA antagonist + iNOS inhibitor + neuroprotective in TBI models. Mechanistic overlap with NAC's glutamate axis but different molecular target. Both d…
  • alcohol pre/post protocol (anecdotal but mechanistic)Synergistic
    Alcohol metabolism via ADH/ALDH depletes hepatic GSH and produces acetaldehyde. NAC 600-1200 mg pre-drinking + 1200 mg morning-after restores GSH and helps c…
  • Nitroglycerin / organic nitrates (isosorbide mononitrate/dinitrate)Avoid
    NAC potentiates nitrate-induced vasodilation, can cause severe hypotension + headache. Documented interaction. Not relevant to Dylan but absolute contraindic…
  • Activated charcoal (acute poisoning context)Avoid
    NAC binds activated charcoal, reducing absorption. In paracetamol overdose, charcoal and NAC are spaced apart by hours. Not a daily-stack concern.
  • Carbamazepine, antipsychotics, antiepileptics — theoreticalAvoid
    NAC can shift glutamate tone; in patients on glutamate-modulating drugs, monitor. No documented bad interactions but worth flagging for psych populations.
  • Anticoagulants (warfarin, DOACs) at high NAC dosesAvoid
    Theoretical antiplatelet potentiation. Sub-clinical at 1200 mg/day. Not relevant to Dylan.
References33 sources
Was this helpful?
Your feedback shapes what we research deeper.
Continue: Extended Research →
Our verdict, decision matrix, deep dives, controversies, sources

Related compounds

Cross-referenced from N-Acetyl-Cysteine (NAC)

More in Supplement · Powder

10 compounds in bucket